c-Met activation promotes extravasation of hepatocellular carcinoma cells into 3D-cultured hepatocyte cells in lab-on-a-chip device

Activation of c-Met signaling is associated with an aggressive phenotype and poor prognosis in hepatocellular carcinoma (HCC); however, its contribution to organ preference in metastasis remains unclear. In this study, using a Lab on a Chip device, we defined the role of aberrant c-Met activation in regulating the extravasation and homing capacity of HCC cells. Our studies showed that (i) c-Met overexpression and activation direct HCC cells preferentially towards the hepatocytes-enriched microenvironment, and (ii) blockage of c-Met phosphorylation by a small molecule inhibitor attenuated extravasation and homing capacity of HCC cells. These results, thus, demonstrate the role of c-Met signaling in regulating the colonization of HCC cells preferentially in the liver.

Automated summary

This study investigated the role of aberrant c-Met activation in regulating the extravasation and homing capacity of hepatocellular carcinoma (HCC) cells using a Lab on a Chip device. It was found that c-Met overexpression and activation directed HCC cells towards the hepatocytes-enriched microenvironment, and blocking c-Met phosphorylation attenuated the extravasation and homing capacity of HCC cells.